Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Filings indexed 362 across all filing types
Latest filing 2023-12-13 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
关于监事会主席辞职暨补选非职工代表监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the chairman of the supervisory board and the nomination of a new non-employee representative supervisor. It includes details about the resignation, the nomination, and the upcoming shareholder meeting to approve the nomination. There are no financial statements, audit results, or detailed financial data. The document is a formal announcement about changes in the company's supervisory board, which falls under Board/Management Information (MANG). The document length is short and it is not a report or a presentation but an official announcement of management changes.
2023-12-13 Chinese
关于医疗器械变更注册的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding a change in the registration of a medical device (three-dimensional cardiac electrophysiology mapping system) approved by the National Medical Products Administration (NMPA). It details the changes in the product structure and scope of application, the registration certificate number, and the impact on the company. The document is a regulatory announcement about a product registration change, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document length is short (1647 characters) and it is clearly an announcement of a regulatory approval/change. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-11-21 Chinese
关于召开2023年第三季度业绩说明会的公告
Call Transcript Classification · 85% confidence The document is an announcement about the scheduling and details of a 2023 third quarter earnings explanation meeting (业绩说明会) to be held online. It references the prior release of the 2023 third quarter report but does not contain any financial data or results itself. The document invites investors to participate and ask questions during the meeting. This type of document is a notice about an upcoming earnings call or investor presentation rather than the transcript or the report itself. Given the nature of the announcement and the focus on the meeting details and investor interaction, the best classification is 'Call Transcript' (CT) because it relates to an earnings explanation meeting, which is a form of conference call or investor call. However, since this document is only the announcement of the meeting and not the transcript, it could also be considered a Regulatory Filing (RNS). But the content is specifically about an earnings explanation meeting, which aligns more closely with the Call Transcript category as per the definitions. Confidence is high due to clear references to the earnings explanation meeting and investor Q&A format.
2023-11-14 Chinese
关于高级管理人员离职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management officer, specifically the marketing vice general manager. It details the resignation, effective date, and confirms no impact on company operations. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2023-11-08 Chinese
独立董事关于第三届董事会第六次会议相关事项的事前认可意见
Regulatory Filings
2023-10-26 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司使用部分募集资金向全资子公司借款用于实施募投项目的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a securities company (华泰联合证券有限责任公司) regarding the use of part of the company's raised funds to lend to its wholly-owned subsidiary for implementing a fundraising investment project. It includes specifics about the fundraising, investment projects, board approvals, regulatory compliance, and audit confirmations. The document is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a formal verification or audit opinion related to the use of raised funds, which aligns with the category of Audit Report / Information (AR). The document length is 4039 characters, which is substantial and contains detailed financial and regulatory information, not just an announcement or summary. Therefore, the best classification is AR (Audit Report / Information). FY 2023
2023-10-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.